Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.115 CHF | -6.50% | -27.90% | +150.00% |
Apr. 24 | Top Premarket Decliners | MT |
Apr. 18 | Transcript : Addex Therapeutics Ltd, 2023 Earnings Call, Apr 18, 2024 |
Sales 2024 * | - | Sales 2025 * | 10.75M 11.77M | Capitalization | 14.75M 16.15M |
---|---|---|---|---|---|
Net income 2024 * | -6M -6.57M | Net income 2025 * | - 0 | EV / Sales 2024 * | - |
Net cash position 2024 * | 362K 397K | Net cash position 2025 * | 7.23M 7.91M | EV / Sales 2025 * | 0.7 x |
P/E ratio 2024 * |
-1.28
x | P/E ratio 2025 * |
2.09
x | Employees | 23 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.48% |
Latest transcript on Addex Therapeutics Ltd
1 day | -6.50% | ||
1 week | -27.90% | ||
Current month | +20.29% | ||
1 month | +25.00% | ||
3 months | +62.89% | ||
6 months | +124.61% | ||
Current year | +150.00% |
Managers | Title | Age | Since |
---|---|---|---|
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 38 | 17-05-31 |
Chairman | 75 | 09-04-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jake Nunn
BRD | Director/Board Member | 54 | 18-05-31 |
Tim Dyer
FOU | Founder | 56 | 01-12-31 |
Chairman | 75 | 09-04-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.115 | -6.50% | 364,591 |
24-04-24 | 0.123 | -9.23% | 1,407,251 |
24-04-23 | 0.1355 | -12.01% | 1,412,204 |
24-04-22 | 0.154 | +2.33% | 496,464 |
24-04-19 | 0.1505 | -5.64% | 894,095 |
Delayed Quote Swiss Exchange, April 25, 2024 at 11:31 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+150.00% | 17.26M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- ADXN Stock